Radio theranostics in paragangliomas and pheochromocytomas.
Feocromocitoma
Paraganglioma
Pheochromocytoma
Teragnosis
Theranostics
[(131)I]MIBG
[(177)Lu]Lu-DOTA-TATE
Journal
Revista espanola de medicina nuclear e imagen molecular
ISSN: 2253-8089
Titre abrégé: Rev Esp Med Nucl Imagen Mol (Engl Ed)
Pays: Spain
ID NLM: 101770941
Informations de publication
Date de publication:
10 May 2024
10 May 2024
Historique:
received:
20
04
2024
accepted:
02
05
2024
medline:
13
5
2024
pubmed:
13
5
2024
entrez:
12
5
2024
Statut:
aheadofprint
Résumé
This continuing education aims to present in a clear and easy-to-understand manner the biology of paragangliomas and pheochromocytomas (PPGLs), the functional imaging studies available for their diagnosis and therapeutic planning, the requirements necessary to administer radioligand therapy (RLT) and the characteristics of these treatments (inclusion criteria, administration protocols, adverse effects and future perspectives). In this pathology we have two RLT options: [
Identifiants
pubmed: 38735639
pii: S2253-8089(24)00033-8
doi: 10.1016/j.remnie.2024.500017
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
500017Informations de copyright
Copyright © 2024. Published by Elsevier España, S.L.U.